jhonson and jhonson by fuuast

7/29/2019 jhonson and jhonson by fuuast

1/26


2/26

PRESENTATORS

ASFANDYAR KHAN

FARHAN NIZAMIFAIZAN SHEIKH

FAIZ-UD-DIN

SANAULLAH KHAN


3/26


4/26

Overview of Johnson & JohnsonA Broadly Based Health Care

CompanyJohnson & Johnson is the worlds mostcomprehensiveandbroadly basedmanufacturer of health care products and

services for theconsumer, pharmaceutical,and medical & diagnosticsmarkets.

The Corporation achieved this leadership byconcentrating on a unique form ofdecentralized management, following theethical principles embodied in our Credoandmanaging the business for thelong term.


5/26

Overview

Headquartered in New Brunswick, NJ

Companies in 57 countries, selling products inmore than 175 countries

2011 sales were US$ 65 billion

Over 110,600 employees worldwide

Extensive worldwide research and supply

chain capabilities

More than US$280 million pa philanthropy


6/26

Founded in 1886.

Founded by :

ROBERT WOOD-1

JAMES WOOD JOHNSONEDWARD MEAD JPHNSON


7/26

This is the illustration of the fist building of johnson &johnson company

This factory was been set up beside the railroad

By 1907 , J&J expanded from a single building to 35 buildings .

By the same year 2500 employees were working .


8/26

Robert Wood Johnson-1 :1887-1910

James Wood Johnson :1910-1932

Robert Wood Johnson-2 :1932-1963

Philip B. Hofmann :1963-1973Richard B. Sellars :1973-1976

James E. Burke :1976-1989

Ralph S. Larsen :1989-2002William C. Weldon :2002-


9/26

Mission/Vision StatementJohnson & Johnson, a global

company, posts that "The fundamentalobjective of Johnson & Johnson is to

provide scientifically sound, highquality products and services to helpheal, cure disease and improve the

quality of life."


10/26

Sales Results By Segment

35% 17

%

47%Medical

Devices &Diagnostic

Consumer

Pharmaceutical


11/26

Consumer Health Care

Skin care Baby care

Wound care

Oral care Over-the-

Counter-Drugs

and Vitamins


12/26

Medical Devices & Diagnostics

Diabetes

Ortho-clinical

Chordis

Depuy Vision care


13/26

Pharmaceuticals

Duragesic

Risperdal 1

Risperdal 2

Concerta Topamax

Procrit

Aciphex


14/26

RoC BRILLIANCE

Starts working immediately to

reduce the appearance of dark

circles and puffiness and is

clinically proven to smooth andtighten the look of delicate skin

around the eyes.

NEUTROGENA Rapid Clear SorePimple Gel

Instantly cools to soothe sore

pimples and clinically proven to

reduce the size, redness and

swelling of sore pimples in just 8

hours.


15/26

Competitors

Abbott Laboratories:Abbott laboratories is engaged in discovery,development, manufacture and sale of avariety of health care products through fourbusiness segments: Pharmaceutical,Diagnostics, Nutritional and Vascular products.

Merck & Co. Inc.:A top competitor is Merck & Co. which offerstreatment and medication four adults andchildren over a wide range of application.Merck has a strong position in the world ofpharmaceutical with such advancements as

Gardasil, the world first anticancer vaccine,Diabetes medication eye disease treatmentand multiple Cardio Vascular drugs such asCozaar and Hyzaar.


16/26

Novartis:Novartis offer over 60 pharmaceutical products

including one of the most well known drugs,ritalin, and has received more approvals thanany other pharmaceutical company in theindustry since 2000

Pfizer:Pfizer has tow segments: Pharmaceutical, which

develops and produces products that treatcardio vasular and metabolic diseases, centralnervous system disorders, cancer, eye diseaseetc. and Animal Health, which disvovers,develops and sells products for the prevention

and treatment of diseases in livestock andcompanion animals.


17/26

STRATEGIES

Strategic AcquisitionsJohnson & Johnson has maintained a stable

financial position by utilizing cash reserves tofinance timely corporate acquisitions. Its Triple

A Credit Rating represents a company able to

take advantage of opportunities that arisewithout being limited by burdensome levels ofdebt.


18/26

Product Diversification

The Johnson & Johnson pharmaceutical portfolio,and ts large Medical Devices & Diagnostics (M,D&D) and Consumer Health divisions serves toreduce dependence upon any one area. The

company plans to continue this broadeningthrough 2008-14. This diversification allows awider range of choice when pursuing opportunitieswith the greatest growth prospects.


19/26

Positive RevenueGrowth Projections

The potential of an impressive number of new productlaunches and the promise of achieving forecastsales is said to bode well for Johnson & Johnson,helping it weather the recent decline in prescriptionpharmaceuticals and projecting a turn-around

through 2010. An increase at 1.8% CAGR across200814 is believed to be achievable.


20/26

Distribution Strategy

Currently all productpurchasing is online and

delivery is directly made to useraddress


21/26

SWOT Analysis Strengths:

Broad diversity of products. Not reliant on a soleproduct line for majority of revenue.

Repeat customers. People tend to be brand-loyal.If they buy Tylenol for their headaches, they tendto repeatedly buy Tylenol.

Strong brands. "No more tears" shampoo, Band-

Aid, Tylenol, Visine, etc. Generally smart purchasing of companies. For

instance, it didn't purchase


22/26

WEAKNESS A conglomerate of relatively independent

companies. Sometimes they can go off thereservation, such as what appears to havehappened with McNeil Consumer Healthcare andthe making of the children's medicine now beingrecalled.

Several of its big drugs have lost or will soon losepatent protection.

Many of its products are commodities. Forinstance, other adhesive bandages exist, not justBand-Aid.

OPPORTUNITIES Development of personalized drugs that work best

on specific genetic profiles, such as Gleevecfrom Novartis

Continued smart purchasing of companies withcomplementary products.


23/26

THREATS

Increasing pressure to move to generic drugs.

Stiff competition instants, especially from AbbottLabs , Boston Scientific, and Medtronic , andhaving to keep one step ahead of everyone else.


24/26

Environmental Analysis

Political factor

Economic factor

Socio-cultural factor

Technological factor


25/26

Future

Over the past two decades, Johnson & Johnsonhas continued to set and meet a series of long-term targets across a range of environmentalimpacts including Pollution Prevention Goals,Next Generation Goals, and its most recently

completed Healthy Planet 2010 Goals.. The nextstep in its evolution was to go bolder and broaderwith Healthy Planet 2015 Goals..

At the heart ofHealthy Planet 2015 Goalsare 15of the boldest and broadest sustainability goals wehave set to date and extend well beyondenvironmental stewardship to include an emphasison improving peoples health, increasing corporate

transparency and encouraging collaborativepartnerships.


26/26

Documents

jhonson and jhonson by fuuast